# 68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)

> **NCT04854369** · — · NO_LONGER_AVAILABLE · sponsor: **Tulane University**

## Conditions studied

- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant

## Interventions

- **DRUG:** 68 Ga-PSMA-11 prepared using a PSMA-11 Sterile Cold Kit

## Key facts

- **NCT ID:** NCT04854369
- **Lead sponsor:** Tulane University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2023-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854369, "68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04854369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*